1. Slomovitz BM, Lavery RF, Tortella BJ, Siegel JH, Bachl BL, Ciccone A: Validation of a hand held lactate device in determination of blood lactate in critically injured patients. Critical Care Medicine 26(9):1523-1528, 1998.

2. Lavery RF, Livingston DH, Tortella BJ, Sambol JT, Slomovitz BM, Siegel JH: The utility of venous lactate to triage injured patients in the trauma center. Journal of the American College of Surgery 190(6): 656-664, 2000.

3. Slomovitz BM, Girotra M, Aledo A, Saqi A, Soslow RA, Spigland NA, Caputo TA: Desmoplastic small round cell tumor with primary ovarian involvement: Case report and review. Gynecol Oncol 79(1): 124-128, 2000.

4. Soslow RA, Slomovitz BM, Saqi A, Baergen RN, Caputo TA: Tumor suppressor gene, cell surface adhesion molecule and multi-drug resistance in Mullerian serous carcinomas: Clinical divergence without immunophenotypic differences. Gynecol Oncol 79(3): 430-437, 2000.

5. Nezhat F, Slomovitz BM, Saiz AD, Cohen CJ: Ovarian mucinous cystadenocarcinoma with virilization. Gynecol Oncol 84(3): 468-72, 2002.

6. Slomovitz BM, Caputo TA, Gretz HF 3rd, Economos K, Tortoriello DV, Schlosshauer PW, Baergen RN, Isacson C, Soslow RA: A comparative analysis of 57 serous borderline tumors with and without a noninvasive micropapillary component. American Journal of Surgical Pathology 26(5):592-600, 2002.

7. Slomovitz BM, Soslow RA, Chang RC, Golub R, Kuo DY: Serous adenocarcinoma of the inguinal region arising from endometriosis followed by a successful pregnancy: a case report. Gynecol Oncol 87, 152-4, 2002.

8. Wu W, Slomovitz BM, Celestino J, Chung L, Thornton A, Lu KH: Coordinate expression of Cdc25B and estrogen receptor A is present in low grade type I endometrial carcinoma but absent in high grade and type II endometrial carcinoma. Cancer Research 63(19):6195-9, 2003.

9. Slomovitz BM, Burke TW, Oh JC, Broaddus RR, Eifel PJ, Atkinson EN, Silva EG, Gershenson DM, Lu KH: Clinical and pathologic characteristics of uterine papillary serous carcinoma: a single institution review of 129 cases. Gynecol Oncol, 91: 463-469, 2003.

10. Slomovitz BM, Broaddus RR, Burke TW, Sneige N, Soliman PT, Wu W, Sun CC, Munsell M, Gershenson DM, Lu KH. Her-2/neu overexpression and amplification in uterine papillary serous carcinoma. Journal of Clinical Oncology, 22(15):3126-32, 2004.

11. Frumovitz M, Slomovitz BM, Broaddus RR, Abrams J, Sun CC, Bevers M, Bodurka DC. Endometrial Cancer: to stage or not to stage. JACS 199:388-393, 2004.

12. Soliman PT, Slomovitz BM, Broaddus RR, Sun CC, Oh JC, Eifel PJ, Gershenson DM, Lu KH. Synchronous primary cancers of the endometrium and ovary: a single institution review of 84 cases. Gynecol Oncol 94:456-62, 2004.

13. Slomovitz BM, Sun CC, Ramirez PT, Bodurka DC, Diaz P, Lu KH. Does Tamoxifen Use Affect Prognosis in Breast Cancer Patients Who Develop Endometrial Cancer? Obstet Gynecol 104:255-260, 2004.

14. Slomovitz BM, Broaddus RR, Schmandt R, Wu W, Oh JC, Ramondetta LM, Burke TW, Gershenson DM, Lu KH. Expression of imatinib mesylate-targeted kinases in endometrial carcinoma. Gynecol Oncol 95(1):32-6, 2004.

15. Caudell JJ, Deavers MT, Slomovitz BM, Lu KH, Broaddus RR, Gershenson DM, Ramondetta LM. Imatinib mesylate (gleevec)-targeted kinases are expressed in uterine sarcomas. Appl Immunohistochem Mol Morphol 13(2):167-70, 2005.

16. Lee CM, Slomovitz BM, Greer M, Sharma S, Gregurich MA, Burke T, Lu KH, Ramondetta LM. Practice patterns of SGO members for stage IIIA endometrial cancer. Gynecol Oncol 98(1):77-83, 2005.

17. Soliman PT, Oh JC, Schmeler KM, Sun CC, Slomovitz BM, Gershenson DM, Burke TW, Lu KH. Risk factors for young premenopausal women with endometrial cancer. Obstet Gynecol 105(23):575-80, 2005.

18. Slomovitz BM, Ramondetta LM, Lee CM, Oh JC, Eifel PJ, Jhingran A, Burke TW, Gershenson DM, Lu KH. Heterogeneity of stage IIIA endometrial carcinomas: implications for adjuvant therapy. Int J Gynecol Cancer 15(3):510-6,2005.

19. Bristol I, Brown J, Slomovitz BM, Shannon VR, Eifel PJ. Methemoglobinemia induced by topical vaginal sulfanilamide cream in a patient with cervical cancer: a case report. Gynecol Oncology, 97(3): 953-6, 2005.

20. Rubatt JM, Slomovitz BM, Burke TW, Broaddus RR. Development of metastatic endometrial endometrioid adenocarcinoma while on progestin therapy for endometrial hyperplasia. Gynecologic Oncology, 99(2):472-6, 2005.

21. Ramirez PT, Sun CC, Vidal CI, Schimp V, Slomovitz BM, Bevers MW, Bodurka DC. Outcomes of hysteroscopy and hysterectomy in breast cancer patients. Cancer Therapy, 3: 147-152, 2005.

22. Schmeler K, Soliman PT, Sun CC, Slomovitz BM, Gershenson DM, Lu KH. Endometrial cancer in young, normal-weight women. Gynecologic Oncology, 99(2):388-92, 2005.

23. Dietrich CS 3rd, Modesitt SC, Depriest PD, Ueland FR, Wilder J, Reedy MB, Pavlik EJ, Kryscio R, Cibull M, Giesler J, Manahan K, Huh W, Cohn D, Powell M, Slomovitz B, Higgins RV, Merritt W, Hunter J, Puls L, Gehrig P, van Nagell JR, Jr. The efficacy of adjuvant platinum-based chemotherapy in stage I uterine papillary serous carcinoma (UPSC). Gynecologic Oncology 99(3): 557-63, 2005.

24. Soliman PT, Broaddus RR, Schmeler K, Daniels MS, Gonzalez D, Slomovitz BM, Gershenson DM, Lu KH. Women with synchronous primary cancers of the endometrium and ovary: do they have Lynch syndrome? J Clin Oncol 23(36):9344-50, 2005

25. Schmeler K, Lynch H, Chen L, Munsell M, Soliman PT, Clark M., Daniels M, White K, Boyd-Rogers S, Conrad P, Yang K, Rubin M, Sun CC, Slomovitz BM, Gershenson DM, Lu KH. Prophylactic surgery for the reduction of gynecologic cancer risk in women with Lynch syndrome (HNPCC). New England Journal of Medicine, 354(3): 261-269, 2006.

26. Soliman PT, Wu D, Tortolero-Luna G, Schmeler KM, Slomovitz BM, Bray MS, Gershenson DM, Lu KH. Association between adiponectin, insulin resistance, and endometrial cancer. Cancer 106(11): 2376-81, 2006.

27. Ramirez PT, Slomovitz BM, Coleman RL, Soliman PT, Levenback C. Total laparoscopic radical hysterectomy and lymphadenectomy: The M. D. Anderson Cancer Center Experience. Gynecologic Oncology (in press), 2005.

28. Slomovitz BM, Sun CC, Frumovitz M, Soliman PT, Pearson HC, Berenson A, Schmeler K, Ramirez PT, Lu KH ,Bodurka DC. Are women ready for the HPV vaccine? Gynecologic Oncology (in press), 2006.

29. Slomovitz BM, Ramirez PT, Frumovitz M, Soliman PT, Bevers M, Coleman RL, Levenback C. Electrothermal bipolar coagulation for pelvic exenterations. Gynecologic Oncology (in press), 2006.

30. Ramirez PT, Slomovitz BM, McQuinn L, Levenback C, Coleman RL. Role of appendectomy at the time of primary surgery in patients with early-stage ovarian cancer. Gynecol Oncol (in press), 2006.

31. Poynor EA, Marshall D, Sonoda Y, Slomovitz BM, Barakat RR, Soslow, RA. Clinicopathologic features of early adenocarcinoma of the cervix initially managed with cervical conization. Gynecol Oncol (in press), 2006.

32. Wu W, Slomovitz BM, Soliman PT, Schmeler K, Celestino J, Milam MR, Lu KH. Correlation of cyclin D1 and cyclin D3 overexpression with the loss of PTEN expression in endometrial carcinoma. Int J Gynecol Oncology 16(4): 1668-72, 2006.

Letters to the Editor
1. Slomovitz BM, Lu KH. Commenting on: HER2/neu overexpression: has the Achilles heel of uterine serous papillary carcinoma been exposed?, (88:263-5) by Santin et al, Gynecologic Oncology 2004;92:386-7.

2. Slomovitz BM, Bodurka DC, Lu KH. In reply: Does tamoxifen use affect prognosis in breast cancer patients who develop endometrial cancer? Obstetrics and Gynecology, 2005;105:218-9.

Book Chapters
1. Slomovitz BM, Lu KH. Systemic therapy for the treatment of endometrial carcinoma. In: Coukos and Rubin, Cancer of the Uterus, 2004.

2. Slomovitz BM, Soliman PT, Wolf J. Gynecologic Cancer. In: Feig, Berger and Fuhrman, The M.D. Anderson Surgical Oncology Handbook, 2005, in press.

3. Frumovitz M, Slomovitz BM, Bodurka DC. Obstetric and Gynecologic Issues. In: Yeung, Escalante, and Gagel, Internal Medicine Care of Cancer Patients, 2005, in press.

4. Slomovitz BM, Coleman RL. Vaginal Cancer. In: Disaia and Creasman, Clinical Gynecologic Oncology, 2006, in press.


Invited Articles
1. Soliman PT, Slomovitz BM, Wolf JK. Mechanisms of cervical cancer. Drug Discovery Today 2004;1(2):253-8.

2. Slomovitz BM, Soliman PT, Wolf JK. Advances in the management of recurrent ovarian cancer. National Ovarian Cancer Coalition Newsletter, September 2004.

3. Wolf J, Slomovitz BM. Novel biologic therapies for the treatment of endometrial cancer. Int J Gynecol Cancer 2005; 15(2):411.

4. Slomovitz BM, Wolf J, Ramondetta LM, Burke TW, Lu KH. Advances in the management of advanced and recurrent uterine papillary serous carcinoma. Int J Gynecol Cancer 2005; 15(2): 406.